Cargando…

Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy

PURPOSE: The population of elderly patients with epilepsy has been growing rapidly and the chances of referring older patients with refractory epilepsy for surgical options could be increasing. In general, epilepsy surgery at higher ages has been less likely to be performed, because little is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, Naoki, Fujimoto, Ayataka, Okanishi, Tohru, Sato, Keishiro, Enoki, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104207/
https://www.ncbi.nlm.nih.gov/pubmed/32273711
http://dx.doi.org/10.2147/TCRM.S250178
_version_ 1783512191764267008
author Ichikawa, Naoki
Fujimoto, Ayataka
Okanishi, Tohru
Sato, Keishiro
Enoki, Hideo
author_facet Ichikawa, Naoki
Fujimoto, Ayataka
Okanishi, Tohru
Sato, Keishiro
Enoki, Hideo
author_sort Ichikawa, Naoki
collection PubMed
description PURPOSE: The population of elderly patients with epilepsy has been growing rapidly and the chances of referring older patients with refractory epilepsy for surgical options could be increasing. In general, epilepsy surgery at higher ages has been less likely to be performed, because little is known regarding the risks and benefits in elderly patients. We, therefore, investigated surgical outcomes and comorbidities in a population ≥50 years old who underwent epilepsy surgery. METHODS: Patients ≥50 years old who underwent epilepsy surgery were identified from the database of our epilepsy center for the period from 2009 to 2017. Surgical complications and seizure outcome were reviewed, and seizure outcomes were evaluated using the International League Against Epilepsy (ILAE) surgery outcome scale. RESULTS: The mean age of 32 patients at the time of surgery was 56.1±5.1 years. The mean duration of epilepsy was 23.4±18.5 years and mean follow-up was 2.7±2.0 years. As of the most recent visit, 56.3% of patients remained completely seizure-free (ILAE Class I). The surgery-related complication rate was 11.5%, comprising permanent deficits in 3.8% and transient deficits in 7.7%. CONCLUSION: These results suggest that epilepsy surgery may represent a valuable approach in selected adult patients.
format Online
Article
Text
id pubmed-7104207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71042072020-04-09 Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy Ichikawa, Naoki Fujimoto, Ayataka Okanishi, Tohru Sato, Keishiro Enoki, Hideo Ther Clin Risk Manag Original Research PURPOSE: The population of elderly patients with epilepsy has been growing rapidly and the chances of referring older patients with refractory epilepsy for surgical options could be increasing. In general, epilepsy surgery at higher ages has been less likely to be performed, because little is known regarding the risks and benefits in elderly patients. We, therefore, investigated surgical outcomes and comorbidities in a population ≥50 years old who underwent epilepsy surgery. METHODS: Patients ≥50 years old who underwent epilepsy surgery were identified from the database of our epilepsy center for the period from 2009 to 2017. Surgical complications and seizure outcome were reviewed, and seizure outcomes were evaluated using the International League Against Epilepsy (ILAE) surgery outcome scale. RESULTS: The mean age of 32 patients at the time of surgery was 56.1±5.1 years. The mean duration of epilepsy was 23.4±18.5 years and mean follow-up was 2.7±2.0 years. As of the most recent visit, 56.3% of patients remained completely seizure-free (ILAE Class I). The surgery-related complication rate was 11.5%, comprising permanent deficits in 3.8% and transient deficits in 7.7%. CONCLUSION: These results suggest that epilepsy surgery may represent a valuable approach in selected adult patients. Dove 2020-03-25 /pmc/articles/PMC7104207/ /pubmed/32273711 http://dx.doi.org/10.2147/TCRM.S250178 Text en © 2020 Ichikawa et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ichikawa, Naoki
Fujimoto, Ayataka
Okanishi, Tohru
Sato, Keishiro
Enoki, Hideo
Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy
title Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy
title_full Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy
title_fullStr Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy
title_full_unstemmed Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy
title_short Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy
title_sort efficacy and safety of epilepsy surgery for older adult patients with refractory epilepsy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104207/
https://www.ncbi.nlm.nih.gov/pubmed/32273711
http://dx.doi.org/10.2147/TCRM.S250178
work_keys_str_mv AT ichikawanaoki efficacyandsafetyofepilepsysurgeryforolderadultpatientswithrefractoryepilepsy
AT fujimotoayataka efficacyandsafetyofepilepsysurgeryforolderadultpatientswithrefractoryepilepsy
AT okanishitohru efficacyandsafetyofepilepsysurgeryforolderadultpatientswithrefractoryepilepsy
AT satokeishiro efficacyandsafetyofepilepsysurgeryforolderadultpatientswithrefractoryepilepsy
AT enokihideo efficacyandsafetyofepilepsysurgeryforolderadultpatientswithrefractoryepilepsy